Tarbox Family Office, Inc. - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 159 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tarbox Family Office, Inc. ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$1,0000.0%220.0%0.00%
Q3 2021$1,0000.0%220.0%0.00%
Q2 2021$1,0000.0%220.0%0.00%
Q1 2021$1,0000.0%220.0%0.00%
Q4 2020$1,0000.0%220.0%0.00%
Q3 2020$1,0000.0%220.0%0.00%
Q2 2020$1,000
-50.0%
22
-56.0%
0.00%
-100.0%
Q1 2020$2,000
+100.0%
50
+78.6%
0.00%
Q4 2019$1,0000.0%28
+21.7%
0.00%
Q2 2019$1,000
-50.0%
230.0%0.00%
-100.0%
Q1 2019$2,000
+100.0%
230.0%0.00%
Q4 2018$1,0000.0%23
+43.8%
0.00%
Q3 2018$1,0000.0%160.0%0.00%
Q2 2018$1,0000.0%160.0%0.00%
Q1 2018$1,0000.0%160.0%0.00%
Q4 2017$1,0000.0%160.0%0.00%
Q3 2017$1,0000.0%160.0%0.00%
Q2 2017$1,0000.0%160.0%0.00%
-100.0%
Q1 2017$1,0000.0%160.0%0.00%0.0%
Q4 2016$1,0000.0%160.0%0.00%0.0%
Q3 2016$1,0000.0%160.0%0.00%0.0%
Q2 2016$1,0000.0%160.0%0.00%0.0%
Q1 2016$1,000160.00%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Flagship Ventures 2007 General Partner LLC 1,930,369$118,428,00083.56%
Third Rock Ventures, LLC 3,070,090$188,350,00021.97%
Opaleye Management Inc. 113,500$6,963,225,0005.43%
BB BIOTECH AG 1,890,521$115,983,0004.72%
Eventide Asset Management 431,600$26,479,0003.70%
Atika Capital Management LLC 54,000$3,313,0002.55%
Cormorant Asset Management, LP 100,000$6,135,0001.26%
BRIDGER MANAGEMENT, LLC 220,099$13,503,0000.92%
Ghost Tree Capital, LLC 20,000$1,227,0000.67%
HAMILTON LANE ADVISORS LLC 27,544$1,690,0000.55%
View complete list of AGIOS PHARMACEUTICALS INC shareholders